Botanix Pharmaceuticals Ltd (BOT)

Currency in AUD
0.150
+0.005(+3.45%)
Closed·

BOT Earnings

Latest Release
May 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
700.00K / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/----/12.3M----Free Sign Up
03/2025--/--700K/------Free Sign Up
12/2024-0.02/--377.6K/------Free Sign Up
12/2022--/--388K/------Free Sign Up
06/2022-0.01/--13.47K/------Free Sign Up
12/2021-0.01/--23.9K/------Free Sign Up
06/2021--/--14.92K/------Free Sign Up
12/2020--/--88.87K/------Free Sign Up
06/2020-0.01/--76.79K/------Free Sign Up
12/2019-0.01/--103.8K/------Free Sign Up

All numbers in AUD

Botanix Pharmaceuticals Ltd Earnings Call Summary for Q4/2025

  • Botanix Pharma's Q4 2025 gross sales surged to $20.4M, up from $4.8M in Q3, driven by successful Softra launch
  • Prescriptions increased 324% following Softra launch; operating cash flow improved by $8.4M to $28.4M
  • Company aims to expand sales force to 50 reps by FY2026, targets 30-40% gross-to-net yield and cash flow positivity
  • FY2025 and FY2026 revenue forecasts set at $3.78M and $42.9M respectively; $64.9M cash and $27M inventory on hand
  • Stock gained 9.68% in past week; market cap at $218.85M, trading near 52-week range of $0.09-$0.35
Last Updated: 28/07/2025, 00:40
Read Full Transcript

FAQ

What Is Botanix Pharma's Earnings Per Share (TTM)?

The Botanix Pharma EPS (TTM) is -0.02.

When Is The Next Botanix Pharma Earnings Date?

Botanix Pharma will release its next earnings report on 27 Aug 2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.